MBCL-25. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA: UPDATED OUTCOMES

BACKGROUND: Wnt+ medulloblastoma (WPM) is a favorable subtype with EFS > 90% when treating postoperatively with craniospinal irradiation and posterior fossa boost (CSI/XRT) followed by adjuvant chemotherapy. This pilot study explored the safety of omitting radiation in standard-risk WPM. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Kenneth, Chi, Susan, Hawkins, Cynthia, Rodriguez, Fausto, London, Wendy, Castellino, Robert Craig, Aguilera, Dolly, Stapleton, Stacie, Ashley, David, Landi, Daniel, Bandopadhayay, Pratiti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715534/
http://dx.doi.org/10.1093/neuonc/noaa222.501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715534/
http://dx.doi.org/10.1093/neuonc/noaa222.501

Ejemplares similares